Latest NewsJun 18, 2025HiFiBiO Therapeutics to Present Preclinical Data of Three Leading I&I Programs at the 2025 Annual Meeting of the Federation of Clinical Immunology SocietiesAll Filter By: Year20252024202320222021202020192018201720162015Apr 12, 2021HFB9-2, a novel Galectin 9 neutralizing antibody for the treatment of AML and other cancersApr 12, 2021Mechanism of Action and Biomarker Strategy for HFB200301, an Anti-TNFR2 Agonist Antibody for the Treatment of CancerApr 12, 2021Discovery and characterization of a novel anti-human CXCR5 antibody for the treatment of B cell lymphomasApr 6, 2021HiFiBiO Therapeutics to Present Progress on Four Novel Immunotherapy Programs at AACR 2021Mar 19, 2021HiFiBiO and Gustave Roussy Researchers Demonstrate the Contribution of Galectin-9 (Gal-9) in Tumor Immune Escape< 1 … 7 8 9 10 11 … 17 >
